E. Bachy, R. Houot, and F. Morschhauser, Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma, Haematologica, vol.98, pp.1107-1121, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00933219

M. Ghielmini, U. Vitolo, and E. Kimby, ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL), Ann Oncol Off J Eur Soc Med Oncol ESMO, vol.24, pp.561-76, 2013.

G. S. Nowakowski and S. M. Ansell, Therapeutic targeting of microenvironment in follicular lymphoma, Hematol Educ Program Am Soc Hematol Am Soc Hematol Educ Program, vol.2014, pp.169-73, 2014.

T. Relander, N. A. Johnson, P. Farinha, J. M. Connors, L. H. Sehn et al., Prognostic factors in follicular lymphoma, J Clin Oncol Off J Am Soc Clin Oncol, vol.28, pp.2902-2915, 2010.

P. Solal-céligny, P. Roy, and P. Colombat, Follicular lymphoma international prognostic index, Blood, vol.104, pp.1258-65, 2004.

M. Federico, M. Bellei, and L. Marcheselli, Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project, J Clin Oncol Off J Am Soc Clin Oncol, vol.27, pp.4555-62, 2009.

C. Casulo, M. Byrtek, and K. L. Dawson, Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study, J Clin Oncol Off J Am Soc Clin Oncol, vol.33, pp.2516-2538, 2015.

A. Pastore, V. Jurinovic, and R. Kridel, Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry, Lancet Oncol, vol.16, pp.1111-1133, 2015.

V. Jurinovic, R. Kridel, and A. M. Staiger, Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy, Blood, vol.128, pp.1112-1132, 2016.

S. S. Dave, G. Wright, and B. Tan, Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells, N Engl J Med, vol.351, pp.2159-69, 2004.

D. De-jong, A. Koster, and A. Hagenbeek, Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols, Haematologica, vol.94, pp.70-77, 2009.

D. De-jong and T. Fest, The microenvironment in follicular lymphoma, Best Pract Res Clin Haematol, vol.24, pp.135-181, 2011.

B. Sander, D. De-jong, and A. Rosenwald, The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium, Haematologica, vol.99, pp.715-740, 2014.

R. Kridel, L. Xerri, and B. Gelas-dore, The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association, Clin Cancer Res, vol.21, pp.3428-3463, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01543697

G. Salles, J. F. Seymour, and F. Offner, Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial, Lancet, vol.377, pp.42-51, 2011.

S. H. Swerdlow, E. Campo, and N. L. Harris, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Fourth Edition-WHO-OMS-, 4th edn, 2008.

B. D. Cheson, S. J. Horning, and B. Coiffier, Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group, J Clin Oncol Off J Am Soc Clin Oncol, vol.17, p.1244, 1999.

M. J. Maurer, E. Bachy, and H. Ghesquières, Early event status informs subsequent outcome in newly diagnosed follicular lymphoma, Am J Hematol, vol.91, pp.1096-101, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01492002

H. Uno, T. Cai, M. J. Pencina, D. Agostino, R. B. Wei et al., On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data, Stat Med, vol.30, pp.1105-1122, 2011.

T. Hothorn and B. Lausen, On maximally selected rank statistics, R News, pp.3-5, 2002.

M. Rotival, T. Zeller, and P. S. Wild, Integrating genome-wide genetic variations and monocyte expression data reveals trans-regulated gene modules in humans, PLoS Genet, vol.7, p.1002367, 2011.
DOI : 10.1371/journal.pgen.1002367
URL : https://hal.archives-ouvertes.fr/inserm-00711658

A. L. Shaffer, G. Wright, and L. Yang, A library of gene expression signatures to illuminate normal and pathological lymphoid biology, Immunol Rev, vol.210, pp.67-85, 2006.

C. Pangault, P. Amé-thomas, and P. Ruminy, Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis, Leukemia, vol.24, pp.2080-2089, 2010.
DOI : 10.1038/leu.2010.223
URL : https://hal.archives-ouvertes.fr/inserm-00570274